Sébastien Belliveau Selected Research

Sébastien Belliveau Research Topics

8	Dyskinesias (Dyskinesia) 03/2024 - 01/2019
6	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2019
4	Parkinsonian Disorders (Parkinsonism) 01/2023 - 01/2021
3	Psychotic Disorders (Schizoaffective Disorder) 11/2021 - 01/2021
1	Cognitive Dysfunction 01/2022
1	Dementia (Dementias) 01/2022

9	Levodopa (L Dopa)FDA LinkGeneric 03/2024 - 01/2019
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2022 - 01/2021
3	Oxidopamine (6 Hydroxydopamine)IBA 03/2024 - 01/2019
3	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2019
2	Glycine Plasma Membrane Transport ProteinsIBA 08/2022 - 11/2021
2	(R)- (N- (3- (4'- fluorophenyl)- 3- (4'- phenylphenoxy)propyl))sarcosineIBA 08/2022 - 11/2021
2	Therapeutic UsesIBA 11/2021 - 01/2021
1	salicylhydroxamic acid (SHAM)IBA 03/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023
1	Amantadine (Aman)FDA LinkGeneric 01/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	N-Methylaspartate (NMDA)IBA 01/2023
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 08/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	ButyrylcholinesteraseIBA 01/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2021
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2019

3	Therapeutics 11/2021 - 01/2019